Comparing cord blood preptin levels in infants of different birth weights
Comparison of Cord Blood Preptin Levels in Infants With Low and High Birth Weight for Gestational Age and Infants of Diabetic Mothers With Those of Normal Birth Weight Infants
NA · Konya City Hospital · NCT06880003
This study looks at the levels of a protein in the blood of newborns with different birth weights to see how it relates to their health, especially for those born to diabetic mothers.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 80 (estimated) |
| Ages | 1 Minute to 5 Minutes |
| Sex | All |
| Sponsor | Konya City Hospital (other) |
| Locations | 1 site (Konya, Karatay) |
| Trial ID | NCT06880003 on ClinicalTrials.gov |
What this trial studies
This study compares cord blood preptin levels in infants categorized as large-for-gestational-age, appropriate-for-gestational-age, and small-for-gestational-age, as well as those born to diabetic mothers. The aim is to explore the relationship between birth weight and preptin levels, a protein associated with insulin secretion and glucose metabolism. Blood samples will be collected from the umbilical cord during delivery to analyze these levels. The findings could provide insights into the metabolic health of newborns based on their birth weight and maternal diabetes status.
Who should consider this trial
Good fit: Ideal candidates include infants classified as large-for-gestational-age, appropriate-for-gestational-age, small-for-gestational-age, and those born to diabetic mothers.
Not a fit: Infants with syndromic appearances or other accompanying diseases, as well as those whose families do not provide consent, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of metabolic health in newborns and inform interventions for those at risk of complications.
How similar studies have performed: While existing studies have focused on preptin in adults, this approach in newborns is novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Large-for-Gestational-Age (LGA) Infants * Appropriate-for-Gestational-Age (AGA) Infants * Small-for-Gestational-Age (SGA) Infants * Infants of Diabetic Mothers (IDM) Exclusion Criteria: * Infants with a syndromic appearance or any accompanying disease * Infants whose families did not provide consent
Where this trial is running
Konya, Karatay
- Melek Buyukeren — Konya, Karatay, Turkey (RECRUITING)
Study contacts
- Principal investigator: MELEK BUYUKEREN — Konya City Hospital
- Study coordinator: MELEK BUYUKEREN
- Email: melekbuyukeren@gmail.com
- Phone: +903323105000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Newborn Morbidity, Newborn Complication, NEWBORN, preptin, UMBİLİCAL CORD BLOOD